Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells for Diabetic Foot
NCT01216865Phase 2Unknown
- Sponsor
- Qingdao University
- Start
- Jan 2011
- Primary completion
- Dec 2012
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in diabetic foot disease (DFD), critical limb ischemia (CLI), sponsored by Qingdao University. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
diabetic foot disease (DFD)critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT01216865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216865.